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Abstract The treatment of patients with chronic ob-
Background – To assist clinicians and re- structive pulmonary disease (COPD) is mainly
searchers in choosing outcome measures palliative, aimed at relieving symptoms and
for patients with chronic obstructive pul- enhancing quality of life. Despite this, routine
monary disease attending routine out- outcome measurement for these patients tends
patient clinics, a comparative assessment to be limited to pathophysiological measures
was undertaken of four questionnaires de- or survival. Methods for assessing health related
signed to reflect the patients’ perception quality of life are therefore required for two
of their physical and emotional health in purposes: to enable discrimination between the
terms of their feasibility, validity, re- degrees of severity in a condition, and to evalu-
liability, and responsiveness to health ate responsiveness to treatment.1 So far there
change. are few instruments for measuring health re-
Methods – Two condition specific ques- lated quality of life in patients with chronic
tionnaires, the St George’s Respiratory bronchitis and emphysema, and none which is
Questionnaire (SGRQ) and Guyatt’s satisfactory for use in routine clinical practice.2
Chronic Respiratory Questionnaire This is surprising since patients experience
(CRQ), and two generic questionnaires, marked deterioration in their quality of life to
the Short Form-36 Health Survey (SF- the extent that even a limited amount of phys-
36) and Euroqol (EQ), were compared for ical activity results in breathlessness which is
their discriminative and evaluative prop- debilitating and disturbing.
erties. Spirometric tests and a walking test The problem for the clinician and the re-
were also performed. One hundred and searcher is the choice of appropriate in-
fifty six adults who were clinically judged struments. The Chronic Respiratory Question-
to have COPD and who attended an out- naire comprises items drawn from problem
patient chest clinic were assessed at re- areas which have been identified by patients
cruitment and six and 12 months later. and their relatives, combined into three stand-
Patients were also asked whether their ardised dimensions – emotional function, fa-
health had changed since their last as- tigue, and mastery – with items for a fourth
sessment. dimension (dyspnoea) being generated in-
Results – Completion rates and con- dividually by each patient.3 The St George’s
sistency between items for dimensions of Respiratory Questionnaire, another stand-
the SGRQ were lower than for dimensions ardised condition specific instrument, covers
of the other questionnaires. The dis- symptoms, activities and the impact of disease,
tributions of responses were skewed for but without the patient generated items.4 Both
certain dimensions in all questionnaires instruments have been designed for a wide
except the CRQ. Validity was supported for range of patients with respiratory disorders and
all instruments insofar as patients’ scores independent validation has been recommended
were associated with differences in disease by their respective developers.
School of Health and severity. The generic questionnaires better In addition to condition specific measures,
Related Research reflected other health problems. All in- there is a case for general measures of health(ScHARR) struments were reliable over time. TheR Harper status since there may be side effects of treat-
J E Brazier condition specific questionnaires were ment which are missed by condition specific
S J Walters more responsive between baseline and first instruments. Furthermore, patients with res-N M B Jones follow up visit but this difference did not piratory disease commonly experience co-
persist. While certain dimensions of theDepartment of morbidity such as cardiac and musculoskeletal
Medicine and SF-36 were responsive to patient perceived problems, the symptoms of which will not bePharmacology changes, this did not apply to the derivedJ C Waterhouse covered by COPD specific questions. The
single index of the EQ. The rating scale ofP Howard Short Form-36 Health Survey is a recent gen-
the EQ, however, provided a quick and eric health status questionnaire which has beenUniversity of Sheffield, easy indicator of change. shown to be reliable and sensitive to low levelsSheffield S1 4DA, UK
Conclusions – Evidence from this study of morbidity.5 In work with its predecessor, theCorrespondence to: supports the CRQ and the SF-36 as com-Dr J E Brazier. SF-20, Stewart et al 6 demonstrated significantly
prehensive outcome measures for patients different profiles of scores for patients withReceived 20 December 1996
with longstanding COPD.Returned to authors COPD compared with the general population,20 February 1997 (Thorax 1997;52:879–887) but the SF-36 has not yet been examined forRevised version received
15 July 1997 this group of patients. Finally, given limitedKeywords: chronic obstructive pulmonary disease, qual-Accepted for publication
16 July 1997 ity of life, questionnaires. health care resources, it is necessary to dem-
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onstrate cost effectiveness both within and be- Survey (SF-36) is a self administered general
health questionnaire of 36 items which generatestween disease groups, and for this a single
index value for health is required. The Euroqol a profile of scores across eight dimensions of
health. Scores are transformed to range from 0instrument is a recent example which is easy
to use and brief, but has yet to be tested on to 100, where 100 indicates good health on each
dimension. The Euroqol Classification of Healththis patient group.7
It is possible to use a transition question (EQ) is a recently developed self administered
instrument in two sections, the first measuringwhich asks patients to compare their health
“now” with that on a specified earlier occasion five dimensions of health from which a single
index can be derived (EQ-5D), and the secondin order to assess outcomes. This is well es-
tablished in the field of arthritis8–11 where they a visual analogue rating scale measuring global
health (EQ rating scale). In addition, patientshave been found to correlate with objective
clinical variables. The transition question provided information regarding recent treatments
and their use of health and social services.seems particularly relevant to COPD where
conventional respiratory measures convey little
about the patient’s experience.
In order to assist clinicians and researchers  
Three booklets of questionnaires for self ad-in choosing suitable instruments for dis-
criminative and evaluative purposes in patients ministration were prepared – the first with the
SF-36, the second with the SGRQ, and the thirdwith COPD, we have undertaken a comparative
assessment of the feasibility of using ques- with the EQ. As a measure of disease severity,
the MRC Respiratory Questionnaire12 was in-tionnaires in a routine outpatient clinic
environment and have examined their psycho- cluded in the third booklet as were items on
recent treatments and the use of resources. Thesemetric properties of validity, reliability, and
responsiveness to health change. It has been booklets were handed to the patient after their
consent to participate in the study had beenargued that questionnaires are more responsive
to health change if they are condition specific, obtained. Patients completed the booklets while
waiting in the clinic, took uncompleted sectionsand especially if they are patient generated.
This property has also been tested in this study. home to return promptly, or declined to attempt
any further responses. A researcher was on hand
in the clinic to answer queries about the ques-
tionnaires. The CRQ was administered by in-Methods
 terview to a subsample obtained opportunistically
in the clinic or at home within a few days of theirThis observational study, for which ethical ap-
proval was granted, was carried out in the chest clinic appointment.
Subsequent follow up assessments of all ques-clinic of a city teaching hospital. Native English
speaking patients aged 35 years and over and tionnaires were made after approximately six and
12 months during the patients’ routine ap-clinically judged to have COPD were recruited
over a four month period. Patients with a clin- pointments at the chest clinic. To examine re-
sponsiveness at each follow up the transitionical diagnosis of asthma, occupational and non-
occupational lung fibrosis, and pulmonary question (a modification of item 2 in the SF-36)
was used which asked patients to compare theirmalignancy were excluded, as were those whose
spirometric tests gave FEV1 >70% FVC or health “now” with that “six months earlier”.
FEV1 <70% FVC but with demonstrable re-
versibility. Main diagnosis and comorbidity to-
gether with sociodemographic information were  
The primary purpose of the analysis was to com-obtained from medical records. Routine spiro-
metric and pulse oximetry measures were ob- pare the discriminative and evaluative properties
of the four instruments employed in this study.tained on the day of assessment for all patients
and a subsample of patients was invited to These were assessed, in the baseline and follow
up periods respectively, using descriptive statisticsundertake the six minute walking test (6MWT).
as well as more rigorously for completion, internal
consistency, validity, reliability, and responsive-
ness. All dimensions with missing items have
Patient perceived health was assessed using two been excluded from further analysis except for
the CRQ where the recommended substitutioncondition specific and two generic question-
naires. Of the two condition specific ques- procedure was used.
Internal consistency, the relationship betweentionnaires, the interviewer administered Chronic
Respiratory Questionnaire (CRQ) examines four items within a dimension, was examined using
the non-parametric correlation coefficient fordimensions, with the items relating to the di-
mension of dyspnoea being identified by each item-to-dimension score, corrected for overlap,
in addition to Cronbach’s alpha.patient individually. Using a seven point scale for
responses, the scores for each question for each It is generally recognised that for outcome
measures of health there is no “gold standard”dimension are simply added together. The self
administered St George’s Respiratory Ques- for testing validity. However, one method is to
examine construct validity where hypotheses ortionnaire (SGRQ) employed in this study com-
prises 50 items, using weights derived by its constructs concerning the expected distribution
of health between groups may be examined by thedeveloper from a patient population, and from
which three dimension scores and a total score measures being validated, with the significance of
these differences being tested statistically usingmay be calculated. The Short-Form-36 Health
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standard t tests. The importance of the differences after six months, 53 of whom attempted all four
quality of life questionnaires, and 100 at themay then be investigated by calculating their
effect size, which is the mean difference between second follow up visit after 12 months, 47 of
whom attempted all four questionnaires. Patientsgroups divided by the pooled standard deviation.
This is an indicator of the ability of a measure to were lost to follow up because of death, being
too ill, or being discharged from the chest clinic.discriminate the “signal” from the overall “noise”
or variance. In the present analysis the magnitude
of effect sizes has been judged against the criteria
recommended by Cohen where [0.2 to <0.5, 
The sample comprised 76 men and 80 women[0.5 to <0.8, and [0.8 represent small, mod-
erate, and large changes, respectively.13 Test-retest whose mean (SD) ages were 67 (10.4) years and
62 (10.3) years, respectively. The mean FEV1 forreliability in patients who said their health had
not changed was examined by intra-class cor- the sample was 47% of the predicted value for
their age, height, and sex. Substantial morbidityrelations as a measure of agreement, with the
mean differences between assessments and their was demonstrated, with 77% having to pause for
breath when walking at their own pace on levelconfidence intervals inspected for possible bias.
Responsiveness has been measured in terms of ground, 83% with persistent coughing and 74%
with persistent phlegm. Comorbidity was re-the mean changes in scores between assessments
in those who responded to the transition question corded in the medical records of 47% of cases, of
which half was cardiac and a fifth musculoskeletal.by saying that their health had improved,
worsened, or stayed the same. In order to un- Practically all patients used inhalers while 15%
of patients were on oxygen therapy. In spite ofdertake statistical comparisons of responsiveness,
standardised response means (SRMs) have been their health problems, they received little support
in their homes from health and social serviceestimated for each dimension score by dividing
the mean change between assessments by the workers, but made considerable use of health
services such as GP consultations and hospitalstandard deviation of these changes in scores.
outpatient visits. Seventy seven per cent were
retired or permanently unable to work and, com-
pared with the population of the area,14 they wereResults
 more likely to be in semi-skilled and less likely to
be in professional or managerial occupations.During the four month period 172 patients were
invited to participate in the study. One hundred
and sixty one patients signed consent forms and
11 patients (six men), who were not significantly   
The numbers of items completed varied con-older, refused. After signing consent forms five
patients failed to answer any questionnaires, leav- siderably between instruments and between di-
mensions within each instrument. Completioning a sample of 156 patients. At the initial as-
sessment 152 patients returned the SF-36, 138 rates of 98% were achieved for the administered
CRQ except for the patient generated dimensionthe SGRQ, 142 the EQ, and of the 68 patients
who were approached all agreed to the ad- of Dyspnoea (87%). Of the self completed ques-
tionnaires completion rates for dimensions variedministration of the CRQ by interview; 58 patients
attempted all four quality of life questionnaires from 92–96% (EQ) to 30–76% for the SGRQ.
Completion of the Impact dimension of theat the initial assessment, and 143 completed the
MRC Respiratory Questionnaire. SGRQ, and consequently the Total which is a
composite of three dimensions, was the lowestDuring the follow up periods 128 patients
returned questionnaires at the first follow up visit (43% and 30%, respectively). Two items
Table 1 Descriptive statistics: dimension scores for patients at initial assessment
n Mean (SD) Median % patients on “floor” % patients at “ceiling”
(worst health score) (best health score)
SF-361
Physical functioning 124 29.0 (25.0) 25.0 14.2 0.8
Social functioning 139 45.0 (27.5) 44.4 5.6 7.0
Role limitations (physical) 127 18.1 (32.8) 00.0 68.7 11.5
Role limitations (emotional) 122 44.8 (43.9) 33.3 40.5 34.1
Pain 138 53.1 (28.3) 55.6 4.3 13.5
Mental health 138 64.7 (21.0) 68.0 1.4 3.5
Vitality 133 34.5 (20.1) 35.0 6.6 0.0
General health perception 127 29.2 (18.4) 25.0 6.1 0.0
SGRQ2
Symptoms 105 77.7 (17.1) 80.2 7.4 0.0
Activity 79 80.9 (18.9) 86.5 25.9 0.0
Impact 60 52.5 (18.5) 52.5 0.0 0.0
Total 42 65.4 (15.9) 64.8 0.0 0.0
CRQ3
Dyspnoea 60 14.5 (4.5) 14.0 0.0 0.0
Fatigue 68 13.0 (4.3) 13.0 0.0 0.0
Emotional function 68 29.2 (7.5) 29.0 0.0 0.0
Mastery 68 17.9 (4.9) 19.0 0.0 0.0
EQ1
EQ-5D 125 52.4 (15.7) 53.1 0.0 3.2
Rating scale 132 50.9 (16.4) 50.0 0.8 0.0
1 For SF-36 and EQ: dimensions range from 0 (worst health) to 100 (best health).
2 For SGRQ: dimensions range from 100 (worst health) to 0 (best health).
3 For CRQ: each dimension has its own range.
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tween patients who completed or did not com-
plete the Impact dimension, which was the most
incomplete, were small and not consistent.15
Completion rates for the SGRQ were found to
be slightly higher in the clinic than at home but
they were still substantially below those of the
SF-36 or EQ.15 Completion rates for the SF-
36 varied from 80% for the Role limitations
(emotional) and 82% for Physical functioning to
91% for Pain, Mental health, and Social func-
tioning.
 
By design, all items addressing a dimension of a
questionnaire will be reasonably well correlated.
Items were found to correlate with their hy-
pothesised dimensions by 0.4 or more in 33 of
35 (94%) SF-36 items, 17 of 20 (85%) CRQ
items, and 27 of 50 (54%) SGRQ items. Cal-
culations of Cronbach’s alpha statistic ranged
from 0.75 to 0.99 for the SF-36, 0.71 to 0.84
for SGRQ, and 0.80 to 0.85 for three dimensions
of the CRQ, with the dimension measuring Dys-
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pnoea reaching 0.64. This statistic is not relevant
Figure 1 Effect sizes (mean difference between groups divided by pooled standard to the EQ where there was only one item per
deviation: small [0.2 to <0.5, moderate [0.5 to <0.8, large [0.8) for the dimensions dimension.of the four instruments in relation to breathlessness (cut-off value: having to stop for
breath when walking on level ground at own pace).

Dimension scores were least skewed in the case
of the CRQ, for which no respondents were either
on the “floor” (the worst health score) or the
“ceiling” (the best health score) (table 1). For
the SF-36 the majority of respondents’ scores
were on the “floor” or “ceiling” for the Role
dimensions, while for Physical functioning 35%
of respondents scored in the lowest decile, all of
which indicate constraints on measuring changes
in health from baseline. Only the Activity score
distribution of SGRQ demonstrated an obvious
“floor” effect of 26%. Substantial “ceiling” effects
were observed on all dimensions of the EQ,
although this was not evident in the distribution
of the Rating scale nor the EQ-5D.

Support for construct validity of the SF-36 and
the EQ was provided by a comparison of the
scores profile for COPD patients with an age-
matched and sex-matched sample of the general
population drawn from the same city. This was
markedly different for all dimensions of the SF-
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36 except Mental health. Similarly, patients’
Figure 2 Effect sizes (mean difference between groups divided by pooled standard scores on the EQ indicated poorer health com-deviation: small [0.2 to <0.5, moderate [0.5 to <0.8, large [0.8) for dimensions of
pared with the same matched sample of thethe four instruments in relation to distance walked (metres) on the six minute walking test
(cut-off value: median average for the distance walked (Ζ302 m; >302 m)). general population.16
All questionnaires were found to include di-
mensions which differentiated significantly be-
tween patients on the basis of their experience of(“breathless when sitting or lying still” and “un-
pleasant side effects from my medication”) were breathlessness, where this was defined as severe
if respondents stated that they stopped for breathmissed by 28% and 27% of respondents, re-
spectively, and five items (“breathless when play- when walking on level ground at their own pace
(fig 1).15 (As the numbers of questionnaires avail-ing sports and games”, “medication interferes
with my life”, “chest trouble is a nuisance to my able for comparison varied, a comparison was
made between patients who attempted all fourfamily”, “cannot move far from my bed”, and
“my cough hurts”) were missed by 20% or more questionnaires (n=58) and those who attempted
three or less (n=98). The results for patients inof respondents. Differences in age, sex, FEV1%
predicted, and recent use of health services be- these two groups revealed no significant differ-
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predicted was not systematically related to any
dimensions of any questionnaire.15
In addition to examining intra-questionnaire
characteristics, inter-questionnaire comparisons
may be made. The four questionnaires were com-
pared directly by calculating effect sizes for the
dimension scores in relation to breathlessness,
distance walked in the 6MWT, breathlessness
measured at the end of the 6MWT, and FEV1%
predicted (figs 1–4; directions of signs have been
ignored), and recent hospital admission and co-
morbidity.15 For this purpose, patients were di-
vided into groups representing severe and less
severe breathlessness (fig 1), into two groups
around the median for respiratory indicators (figs
2–4), and according to the presence or absence
of other indicators.15
With regard to breathlessness on exertion, large
effect sizes were observed for Activity, Impact
and Total (SGRQ), Mastery (CRQ), Physical
functioning (SF-36), and the two EQ dimensions;
moderate effect sizes were observed for Dyspnoea
(CRQ), Social functioning, Vitality and General
health perception (SF-36); and small effect sizes
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were seen for Fatigue (CRQ), Symptoms
Figure 3 Effect sizes (mean difference between groups divided by pooled standard (SGRQ), Pain, Mental health and Role lim-
deviation: small [0.2 to <0.5, moderate [0.5 to <0.8, large [0.8) for dimensions of itations (emotional) (SF-36) (fig 1).the four instruments in relation to breathlessness as measured by a visual analogue scale
Tests of exercise tolerance produced some large(VAS; 0=not breathless; 100=severely breathless) at the end of the six minute walking
test (cut-off value: median average for VAS (Ζ65; >65)). or moderate effect sizes for both condition specific
and generic questionnaires (figs 2 and 3). For
FEV1% predicted effect sizes were moderate to
small (fig 4).
Six dimensions of the SF-36 questionnaire
identified patients who had been admitted to
hospital within the last six months. The Pain and
Physical functioning dimensions of the SF-36
and Activity, Impact and Total dimensions of
the SGRQ distinguished the presence of co-
morbidity.15

Reliability over the first interval of six months
was examined for all four instruments, revealing
no evidence of bias between assessments (table
2). The 95% confidence intervals around the
mean differences included zero for all dimensions
except General health perception (SF-36), but
exceeded 10 points (on the 100 point scales) for
five dimensions of the SF-36. Reliability over the
second six month period was similar but with
slightly lower levels of correlation.15

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Responsiveness for groups of patients was first
examined by relating the differences in meanFigure 4 Effect sizes (mean difference between groups divided by pooled standard
deviation: small [0.2 to <0.5, moderate [0.5 to <0.8, large [0.8) for dimensions of scores to patient perceived health change between
the four instruments in relation to FEV1% predicted (cut-off value: median average for initial assessment and first follow up, and between
FEV1% predicted (Ζ41; >41)). first and second follow up visits, and for this
purpose the five categories have been combined
into three – worse, same, and better.
At the first follow up visit the mean scoreences with regard to age, sex, physical and res-
piratory function characteristics and question- differences were associated with the transition
question for the two condition specific ques-naire dimensions with one exception – patients
who completed all four questionnaires walked, tionnaires (SGRQ and CRQ) with results for
patients feeling “better” being associated withon average, further (p=0.01).) Differentiation on
the basis of exercise tolerance, though in the positive changes in scores and those for patients
feeling “worse” being associated with negativeexpected direction, was less impressive (figs 2
and 3).15 The physiological measure of FEV1% changes in scores (table 3). These mean differ-
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(SGRQ) – were large, while Fatigue (CRQ) andTable 2 Intraclass (ri) correlation coefficients and mean differences between scores for
those who said their health had not changed between initial assessment and first follow up Symptoms and Activity (SGRQ) were moderate
(n=58) (fig 5). Of the generic instruments, Physical func-
n ri Mean difference (SD) 95% CI tioning and Social functioning (SF-36) and the
Rating Scale (EQ) showed moderate SRMs. TheSF-36
Physical functioning 35 0.86 −0.4 (11.7) (−4.4 to 3.5) SRM for the EQ-5D, however, failed to reach
Social functioning 49 0.42 −1.6 (26.7) (−9.2 to 6.1) significance.Role limitations (physical) 39 0.21 8.3 (44.9) (−6.1 to 22.7)
Role limitations (emotional) 39 0.18 6.0 (56.1) (−12.0 to 24.0) The picture was not as clear for the second
Pain 47 0.48 −4.3 (27.2) (−3.7 to 12.2) follow up period (fig 6). The sizes of the SRMsMental health 46 0.74 0.4 (15.1) (−4.0 to 4.9)
Vitality 47 0.60 1.6 (16.3) (−3.1 to 6.3) for the symptom dimensions were considerably
General health perception 41 0.44 7.7 (20.2) (1.4 to 14.0) reduced to within the moderate to small range,
SGRQ
and for other dimensions were inconsistent, withSymptoms 34 0.76 1.6 (13.4) (−3.0 to 6.2)
Activity 21 0.74 −1.9 (9.8) (−6.2 to 2.4) the SRM for the EQ-5D again below the criteria.
Impact 16 0.46 −3.3 (16.0) (−7.6 to 0.9)
In the above calculations of responsiveness theTotal 10 0.84 1.2 (8.7) (−4.3 to 6.6)
CRQ† results for all patients were included, which might
Dyspnoea 26 0.77 1.1 (12.2) (−4.2 to 6.4) have served to distort the changes. A more criticalFatigue 25 0.92 0.3 (7.9) (−5.0 to 5.7)
Emotional function 21 0.79 2.8 (13.8) (−2.6 to 8.3) comparison of questionnaires was provided by
Mastery 26 0.84 0.3 (11.9) (−4.4 to 5.1) calculating score changes and SRMs for the same
EQ patients completing the same questionnaires. InEQ-5D 42 0.67 0.8 (11.0) (−3.2 to 4.8)
Rating scale 49 0.65 −0.2 (13.3) (−4.0 to 3.6) this stringent analysis patient groups were in-
evitably small, but the results for the complete† The CRQ dimensions have been transformed onto a 0 (worst function) to 100 (best function)
scale. sample were confirmed.
ences, which systematically reflected the direction
of perceived health change, reached a high degree Discussion
The results of the study have confirmed theof significance for the dimensions of Dyspnoea
and Fatigue in the CRQ and for Symptoms, feasibility of use and the acceptability of three of
the four outcome measures for patients withActivity and Total in the case of SGRQ. For the
generic questionnaires the mean score differences COPD in an outpatient clinic setting, with high
response rates being achieved. The numbers ofreached significance for Physical functioning and
Social functioning while the mean difference in patients attempting the four questionnaires were
not identical, but the results for those attemptingthe EQ rating scale was significant, but not for
the EQ-5D. Mean differences in respiratory func- all four were similar to those who attempted three
or less (data available on request).tion or distance walked in the 6MWT were not
significantly related to perceived health change.15 The SGRQ can be self administered but, with
the minimal supervision provided in this study,These mean changes have been translated into
standardised response means (SRMs) for those levels of item completion were relatively lower
than for the other self administered ques-who reported a health change, in order to permit
a more formal comparison of the responsiveness tionnaires, suggesting low comprehensibility and/
or irrelevance of some items. Furthermore, thereof these instruments (figs 5 and 6). For the first
follow up period the SRMs observed for the were low correlations between some items and
their dimensions, inferring a lack of homogeneity.symptom dimensions of each condition specific
instrument – that is, Dyspnoea (CRQ) and Total Dimensions of the SGRQ which are obviously
Table 3 Mean score differences1 between initial assessment and first follow up in relation to patient perceived health
change
Perceived health change by first follow up
Worse Same Better
Mean (SD) n Mean (SD) n Mean (SD) n p values2
difference difference difference
SF-36
Physical functioning −13.0 (21.8) 30 0.4 (11.7) 35 6.6 (10.9) 16 0.001
Social functioning −10.5 (20.1) 34 1.6 (26.7) 49 13.2 (24.4) 16 0.005
Role limitations (physical) −4.2 (27.1) 30 −8.3 (44.9) 39 13.3 (28.1) 15 0.154
Role limitations (emotion) 7.1 (52.4) 28 −6.0 (56.1) 39 4.4 (45.2) 15 0.58
Pain −1.3 (26.6) 34 4.3 (27.2) 47 −2.5 (17.3) 18 0.51
Mental health −6.8 (20.5) 33 −0.4 (15.1) 46 −2.9 (15.5) 19 0.27
Vitality −6.0 (17.6) 31 −1.6 (16.3) 47 2.1 (14.7) 19 0.23
General health perception −5.7 (14.8) 32 −7.1 (20.2) 41 2.9 (10.9) 18 0.11
SGRQ
Symptoms −6.7 (17.0) 23 1.6 (13.4) 34 16.8 (11.4) 16 0.001
Activity −3.7 (11.7) 19 −1.9 (9.8) 21 10.4 (10.7) 13 0.001
Impact −2.0 (17.3) 13 −3.3 (16.0) 16 12.1 (14.8) 7 0.100
Total −6.8 (12.0) 8 1.2 (8.7) 10 15.1 (9.0) 4 0.008
CRQ
Dyspnoea −9.5 (6.5) 14 −1.1 (12.2) 21 14.9 (16.2) 13 0.001
Fatigue −3.9 (11.4) 16 −0.2 (7.9) 26 11.3 (14.2) 14 0.001
Emotional function −3.4 (13.8) 16 −2.8 (13.8) 26 4.3 (7.7) 14 0.12
Mastery −4.9 (12.0) 16 −0.3 (11.9) 25 4.2 (8.2) 14 0.09
EQ
EQ-5D −5.1 (12.1) 30 −0.8 (11.0) 42 −3.2 (10.7) 22 0.28
Rating scale −10.5 (14.6) 33 0.2 (13.3) 49 3.6 (13.6) 21 0.001
1 Where a mean difference >0 indicates a health improvement.
2 p values from one-way ANOVA to compare mean score differences by perceived health change group.
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before choosing it for an elderly patient group
with long established chest disease.
The CRQ was used in a subsample of patients.
In generating items which cause dyspnoea,
patients provide the clinician with insight into the
restrictions which the disease inflicts on their
activities and life style. Being interviewer ad-
ministered, completion levels were high. In
addition, impressive properties of internal con-
sistency, validity, and responsiveness were
achieved. The widespread use of the CRQ in a
clinic setting, however, is limited by the need for
administration by interview and any version for
self completion would need to be validated on a
national population.
The design of the SF-36 as a measure of
general health status was reflected in its wider
scope to detect comorbidity and recent hospital
admission and thereby indicates its potential
use in assessing side effects of treatment and
the impact of complications. It is clear that the
Role limitations dimensions require re-
designing, for example, to provide five point
scales in place of their Yes/No response format
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as well as instructions to cover more clearly
Figure 5 Standardised response means (SRM=mean change between assessments people who are no longer employed in the
divided by the standard deviation of change: small [0.2 to <0.5; moderate [0.5 to workplace17 18 and in whom the disease onset<0.8; large [0.8) for dimensions of the four instruments for the first follow up period
is later in life. We would not propose to discard(between initial assessment and first follow up period six months later) for those who
reported a change. the dimension as a whole, since the fulfilment
of a person’s role is an important consideration
in the field of rehabilitation medicine. Fur-
thermore, we would add extra items to the
Physical functioning dimension – such as walk-
ing within the home or getting up from a
chair – in order to overcome the “floor” effect
observed in our study.
A single index measure of health is an im-
portant tool for policy makers, applying both
to choices between cost effective treatments
for different groups of patients and to choices
between treatments for the same group, and
was designed for use in economic evaluations.
The EQ in this study has demonstrated ac-
ceptability to patients, high rates of item com-
pletion, a reasonable distribution of responses
for the Rating scale, and clear differentiation
of patients according to the severity of their
disease. The Rating scale, but not the EQ-5D,
has been shown to be responsive to the minor
changes in health which are typical of patients
with chronic disease. Rating scales have been
used with considerable success for other con-
ditions and patient groups,19 their dis-
advantages being that they provide less
information about the nature of the change and
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are inadequate for cross-sectional comparisons.
Figure 6 Standardised response means (SRM=mean change between assessments The results from this study suggest that thedivided by the standard deviation of change: small [0.2 to <0.5; moderate [0.5 to
EQ-5D is inappropriate for use in this patient<0.8; large [0.8) for dimensions of the four instruments for the second follow up period
(between first follow up at six months and second follow up at 12 months) for those who group.
reported a change. In addition to the comparison of appropriate
questionnaires for patients with COPD in an
outpatient setting, this study has contributed
to the discussion of more general issues.related to mobility, such as Activity and Total,
were found to have large and moderate effect With regard to exercise tolerance, the re-
lationship observed between the walking testsizes, clearly discriminating between patients on
the severity of their disease. In addition, the more and physical factors measured by the ques-
tionnaires – such as physical function, activitygeneral dimensions of Activity, Impact and Total
identified the presence of comorbidity. However, and general health status – is not surprising
and leads us to suggest that, if verified inresults obtained with this questionnaire in this
study suggest that some revision may be required other studies, questionnaires could replace the
886 Harper, Brazier, Waterhouse, Walters, Jones, Howard
walking test which many COPD patients find In conclusion, the feasibility of using con-
dition specific (CRQ and SGRQ) and genericonerous. Again, the lack of association between
health related quality of life and objective meas- (SF-36 and EQ) questionnaires with COPD
patients in an outpatient setting has been dem-ures of respiratory function has illustrated the
importance of obtaining subjective health onstrated, with high response rates being
achieved. The discriminative and evaluativemeasures for this group of patients.
Dimensions related to mental health in both properties of the condition specific CRQ and
SGRQ have been confirmed in those patientscondition specific and generic questionnaires
appeared to be less relevant and showed little who completed them. Some revision of the
SGRQ would improve the internal consistencyor no differences between patient groups. Per-
ceived mental health in older people, including and completion of items. Both generic meas-
ures exhibited valid patterns in terms ofthose with chronic ill health, has been reported
to be good in other studies because of patients’ breathlessness and exercise tolerance and com-
parisons on the basis of disease severity, whilelower expectations and coming to terms with
limitations.20 21 the SF-36 provided wider scope. Certain di-
mensions of the SF-36 and the Rating scale ofThis study has provided the first opportunity
to undertake comparisons of responsiveness the EQ, but not the EQ-5D, were responsive
to health change.between the two leading condition specific in-
struments for COPD, both of which have been Results from this study and elsewhere in-
dicate that the optimum strategy in outcomeshown to be responsive to change. The con-
dition specific dimensions were most re- measurement is to use a condition specific
together with a generic instrument. This com-sponsive in the first follow up period, but this
was not repeated in the second follow up bines the advantages of greater responsiveness
with the monitoring of those aspects of healthperiod. A similar result was found by Fitz-
patrick et al10 with respect to attenuated re- especially affected by COPD, as well as pro-
viding a broader picture of a patient groupsponsiveness in the second follow up period of
rheumatology patients. The instability in the with considerable comorbidity. With certain
reservations outlined in the text, the presentdegree of responsiveness, particularly for the
key dimensions of Symptoms and Dyspnoea, evidence suggests that the CRQ, SF-36 and
Rating scale of the EQ are the instruments ofis an interesting finding and clearly requires
exploration in future. It could have implications choice for patients with chronic obstructive
pulmonary disease.for the repeated use of questionnaires in clinical
trials.
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